These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 30012566)

  • 1. The Splicing Factor PTBP1 Promotes Expression of Oncogenic Splice Variants and Predicts Poor Prognosis in Patients with Non-muscle-Invasive Bladder Cancer.
    Bielli P; Panzeri V; Lattanzio R; Mutascio S; Pieraccioli M; Volpe E; Pagliarulo V; Piantelli M; Giannantoni A; Di Stasi SM; Sette C
    Clin Cancer Res; 2018 Nov; 24(21):5422-5432. PubMed ID: 30012566
    [No Abstract]   [Full Text] [Related]  

  • 2. Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM.
    Xie R; Chen X; Chen Z; Huang M; Dong W; Gu P; Zhang J; Zhou Q; Dong W; Han J; Wang X; Li H; Huang J; Lin T
    Cancer Lett; 2019 May; 449():31-44. PubMed ID: 30742945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of PTBP1 promote invasion of colorectal cancer by alternative splicing of cortactin.
    Wang ZN; Liu D; Yin B; Ju WY; Qiu HZ; Xiao Y; Chen YJ; Peng XZ; Lu CM
    Oncotarget; 2017 May; 8(22):36185-36202. PubMed ID: 28404950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of Polypyrimidine Tract-Binding Protein 1 Expression in Colorectal Cancer.
    Takahashi H; Nishimura J; Kagawa Y; Kano Y; Takahashi Y; Wu X; Hiraki M; Hamabe A; Konno M; Haraguchi N; Takemasa I; Mizushima T; Ishii M; Mimori K; Ishii H; Doki Y; Mori M; Yamamoto H
    Mol Cancer Ther; 2015 Jul; 14(7):1705-16. PubMed ID: 25904505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Combination RNAi toward Warburg Effect by Replacement with miR-145 and Silencing of PTBP1 Induces Apoptotic Cell Death in Bladder Cancer Cells.
    Takai T; Yoshikawa Y; Inamoto T; Minami K; Taniguchi K; Sugito N; Kuranaga Y; Shinohara H; Kumazaki M; Tsujino T; Takahara K; Ito Y; Akao Y; Azuma H
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTBP1-mediated biogenesis of circATIC promotes progression and cisplatin resistance of bladder cancer.
    Huang C; Yang Y; Wang X; Chen S; Liu Z; Li Z; Tang X; Zhang Q
    Int J Biol Sci; 2024; 20(9):3570-3589. PubMed ID: 38993556
    [No Abstract]   [Full Text] [Related]  

  • 7. Long noncoding RNA HCG22 suppresses proliferation and metastasis of bladder cancer cells by regulation of PTBP1.
    Jiang D; Zhang Y; Yang L; Lu W; Mai L; Guo H; Liu X
    J Cell Physiol; 2020 Feb; 235(2):1711-1722. PubMed ID: 31304601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skipping of exon 10 in
    Shen L; Lei S; Zhang B; Li S; Huang L; Czachor A; Breitzig M; Gao Y; Huang M; Mo X; Zheng Q; Sun H; Wang F
    Theranostics; 2020; 10(13):5719-5735. PubMed ID: 32483414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polypyrimidine tract-binding protein 1-mediated down-regulation of ATG10 facilitates metastasis of colorectal cancer cells.
    Jo YK; Roh SA; Lee H; Park NY; Choi ES; Oh JH; Park SJ; Shin JH; Suh YA; Lee EK; Cho DH; Kim JC
    Cancer Lett; 2017 Jan; 385():21-27. PubMed ID: 27836735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTBP1 enhances exon11a skipping in Mena pre-mRNA to promote migration and invasion in lung carcinoma cells.
    Li S; Shen L; Huang L; Lei S; Cai X; Breitzig M; Zhang B; Yang A; Ji W; Huang M; Zheng Q; Sun H; Wang F
    Biochim Biophys Acta Gene Regul Mech; 2019 Aug; 1862(8):858-869. PubMed ID: 31075540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal PTBP1 Expression Sustains the Disease Progression of Multiple Myeloma.
    Bai H; Chen B
    Dis Markers; 2020; 2020():4013658. PubMed ID: 32655719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia induced LUCAT1/PTBP1 axis modulates cancer cell viability and chemotherapy response.
    Huan L; Guo T; Wu Y; Xu L; Huang S; Xu Y; Liang L; He X
    Mol Cancer; 2020 Jan; 19(1):11. PubMed ID: 31964396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation and functional significance of CDC42 alternative splicing in ovarian cancer.
    He X; Yuan C; Yang J
    Oncotarget; 2015 Oct; 6(30):29651-63. PubMed ID: 26336992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MYCN controls an alternative RNA splicing program in high-risk metastatic neuroblastoma.
    Zhang S; Wei JS; Li SQ; Badgett TC; Song YK; Agarwal S; Coarfa C; Tolman C; Hurd L; Liao H; He J; Wen X; Liu Z; Thiele CJ; Westermann F; Asgharzadeh S; Seeger RC; Maris JM; Guidry Auvil JM; Smith MA; Kolaczyk ED; Shohet J; Khan J
    Cancer Lett; 2016 Feb; 371(2):214-24. PubMed ID: 26683771
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Huang SP; Chen LC; Chen YT; Lee CH; Huang CY; Yu CC; Lin VC; Lu TL; Bao BY
    Cancer Genomics Proteomics; 2021; 18(3):325-334. PubMed ID: 33893085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTBP1-dependent regulation of USP5 alternative RNA splicing plays a role in glioblastoma tumorigenesis.
    Izaguirre DI; Zhu W; Hai T; Cheung HC; Krahe R; Cote GJ
    Mol Carcinog; 2012 Nov; 51(11):895-906. PubMed ID: 21976412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SON drives oncogenic RNA splicing in glioblastoma by regulating PTBP1/PTBP2 switching and RBFOX2 activity.
    Kim JH; Jeong K; Li J; Murphy JM; Vukadin L; Stone JK; Richard A; Tran J; Gillespie GY; Flemington EK; Sobol RW; Lim SS; Ahn EE
    Nat Commun; 2021 Sep; 12(1):5551. PubMed ID: 34548489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of BCL-X splicing reveals a role for the polypyrimidine tract binding protein (PTBP1/hnRNP I) in alternative 5' splice site selection.
    Bielli P; Bordi M; Di Biasio V; Sette C
    Nucleic Acids Res; 2014 Oct; 42(19):12070-81. PubMed ID: 25294838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PTBP1-mediated repression of neuron-specific CDC42 splicing constitutes a genomic alteration-independent, developmentally conserved vulnerability in IDH-wildtype glioblastoma.
    Yang J; Feng J; Lv J; Chu X; Wei Y; Zhang Y; Li J; Sun Y; Li G; Jiang T; Huang J; Fan X
    Funct Integr Genomics; 2024 Aug; 24(4):135. PubMed ID: 39117866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTBP1 promotes the progression of hepatocellular carcinoma by enhancing the oncogenic splicing switch of FGFR2.
    Chen YY; Zhang Q; Gui MH; Feng L; Cao PB; Zhou GQ
    Yi Chuan; 2024 Jan; 46(1):46-62. PubMed ID: 38230456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.